RXi Pharmaceuticals (RXII)

Add to Watchlists
Create an Alert
0.575 -0.02  -3.36% NASDAQ Aug 18, 20:00 Delayed 2m USD
View Full Chart
RXII Price Chart
View All Performance Charts

RXII Total Returns Comparison

Advertisement

RXII One Page Reports

Edit

Profile

  • URL: http://www.rxipharma.com
  • Investor Relations URL: N/A
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Next Earnings Release: N/A
  • Last Earnings Release: N/A
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: RXi Pharmaceuticals Corp is a clinical-stage RNAi company developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which address significant unmet medical needs.

RXII Comparables

Edit

RXII Excel Add-In Codes

  • Name: =YCI("RXII","name")
  • Description: =YCI("RXII","description")
  • Sector: =YCI("RXII","sector")
  • Industry: =YCI("RXII","industry")
  • Est. Current Fiscal Year End: =YCI("RXII","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.